Citigroup
BVS icon

Citigroup’s Bioventus BVS Stock Holding History

Citigroup’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
38,668
+36,223
+1,482% +$346K ﹤0.01% 4045
2026
Q1 		$22.3K Buy
2,445
+176
+8% +$1.48K ﹤0.01% 4790
2025
Q4 		$16.9K Sell
2,269
-1,693
-43% -$12.2K ﹤0.01% 4915
2025
Q3 		$26.5K Sell
3,962
-14,761
-79% -$102K ﹤0.01% 4719
2025
Q2 		$124K Sell
18,723
-10,298
-35% -$73K ﹤0.01% 4307
2025
Q1 		$266K Sell
29,021
-2,951
-9% -$29.5K ﹤0.01% 4030
2024
Q4 		$336K Buy
31,972
+4,527
+16% +$53.5K ﹤0.01% 4085
2024
Q3 		$328K Buy
27,445
+18,923
+222% +$164K ﹤0.01% 4012
2024
Q2 		$49K Sell
8,522
-121,337
-93% -$666K ﹤0.01% 4593
2024
Q1 		$675K Buy
129,859
+5,336
+4% +$26.1K ﹤0.01% 3344
2023
Q4 		$656K Buy
124,523
+71,990
+137% +$285K ﹤0.01% 3198
2023
Q3 		$173K Buy
52,533
+52,146
+13,474% +$183K ﹤0.01% 3728
2023
Q2 		$1.12K Buy
387
+316
+445% +$606 ﹤0.01% 5328
2023
Q1 		$76 Sell
71
-911
-93% -$1.74K ﹤0.01% 5301
2022
Q4 		$2.56K Sell
982
-16,834
-94% -$73.5K ﹤0.01% 5171
2022
Q3 		$125K Sell
17,816
-1,331
-7% -$10.4K ﹤0.01% 3990
2022
Q2 		$131K Buy
19,147
+1,752
+10% +$17.9K ﹤0.01% 4069
2022
Q1 		$245K Sell
17,395
-799
-4% -$10.7K ﹤0.01% 3960
2021
Q4 		$264K Sell
18,194
-1,331
-7% -$18.9K ﹤0.01% 4191
2021
Q3 		$276K Buy
19,525
+19,130
+4,843% +$294K ﹤0.01% 3954
2021
Q2 		$7K Sell
395
-114
-22% -$1.84K ﹤0.01% 5762
2021
Q1 		$8K Buy
+509
New +$7.25K ﹤0.01% 5747

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citigroup's BVS Position: Q2 2026 in Review

Citigroup increased its Bioventus (BVS) stake by 1,482% in Q2 2026, buying an estimated $346K and bringing the position to 38,668 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #4045.

Citigroup first reported a position in BVS in Q1 2021 and has held it in 22 quarters since. The position peaked at $675K in Q1 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Citigroup held 38,668 shares of Bioventus worth $365K as of Q2 2026.
  • Citigroup bought 36,223 Bioventus shares in Q2 2026, an estimated $346K.
  • Bioventus made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4045 holding.
  • Citigroup first reported a position in Bioventus in Q1 2021 and has held it in 22 quarters since.
  • Citigroup's Bioventus position peaked at $675K in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.